Literature DB >> 27761390

Melanotic neuroectodermal tumour of infancy - A rare entity.

Neelam Noel Andrade1, Paul C Mathai1, Vyankatesh Sahu1, Neha Aggarwal1, Tanvi Andrade1.   

Abstract

Melanotic neuroectodermal tumour of infancy (MNTI) is rare, rapidly growing, pigmented neoplasm of neural crest origin. It is generally accepted as a benign tumour despite of its rapid and locally destructive growth. It primarily affects the maxilla of infants during the first year of life. Surgical excision is considered as the treatment of choice. The recurrence rate varies between 10% and 15%, and malignant behaviour has been reported in 6.5% of cases. We report a case of MNTI, associated with an erupted primary tooth in a 5-month-old male child. We discuss the clinical, radiographic and histologic features of this rare tumour, as well as its surgical management and the follow-up.

Entities:  

Keywords:  Infancy; Melanotic; Neuroectoderm; Paediatric; Pigment; Tumour

Year:  2016        PMID: 27761390      PMCID: PMC5064998          DOI: 10.1016/j.jobcr.2016.06.005

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  9 in total

1.  Congential melanocarcinoma, melanotic adamantinoma, retinal anlage tumor, progonoma, and pigmented epulis of infancy. Summary and review of the literature and report of the first case in an adult.

Authors:  H I LURIE
Journal:  Cancer       Date:  1961 Sep-Oct       Impact factor: 6.860

Review 2.  Melanotic Neuroectodermal Tumor of Infancy: A Systematic Review.

Authors:  Saleh Rachidi; Amit J Sood; Krishna G Patel; Shaun A Nguyen; Heidi Hamilton; Brad W Neville; Terry A Day
Journal:  J Oral Maxillofac Surg       Date:  2015-04-07       Impact factor: 1.895

Review 3.  Melanotic neuroectodermal tumor of infancy: systematic review of the literature and presentation of a case.

Authors:  Birgit Kruse-Lösler; Christoph Gaertner; Horst Bürger; László Seper; Ulrich Joos; Johannes Kleinheinz
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-06-08

Review 4.  Melanotic neuroectodermal tumor of infancy--a neoplasm of neural crese origin. Report of a case associated with high urinary excretion of vanilmandelic acid.

Authors:  E D Borello; R J Gorlin
Journal:  Cancer       Date:  1966-02       Impact factor: 6.860

5.  Melanotic neuroectodermal tumour of infancy (MNTI). Immunohistochemical and ultrastructural study of a case.

Authors:  M Melissari; G Tragni; L Gaetti; M Gabrielli; A Bozzetti; M Raffaini
Journal:  J Craniomaxillofac Surg       Date:  1988-10       Impact factor: 2.078

6.  Melanotic neuroectodermal tumor of infancy: 2 decades of clinical experience with 18 patients.

Authors:  Amit Chaudhary; Ashish Wakhlu; Neetu Mittal; Sanjeev Misra; Divya Mehrotra; A K Wakhlu
Journal:  J Oral Maxillofac Surg       Date:  2009-01       Impact factor: 1.895

7.  Pigmented neuroectodermal tumour of infancy: an immunohistochemical study.

Authors:  R W Stirling; G Powell; C D Fletcher
Journal:  Histopathology       Date:  1988-04       Impact factor: 5.087

Review 8.  Melanotic neuroectodermal tumor of infancy: an ultrastructural study, literature review, and reevaluation.

Authors:  L S Cutler; A P Chaudhry; R Topazian
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

9.  An electron microscope study of a pigmented tumour of the jaw of infants.

Authors:  A F Hayward; B W Fickling; R B Lucas
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

  9 in total
  2 in total

1.  Melanotic neuroectodermal tumor of infancy in the mandible: A case report.

Authors:  Ryoko Takeuchi; Akinori Funayama; Yohei Oda; Tatsuya Abé; Manabu Yamazaki; Satoshi Maruyama; Takafumi Hayashi; Jun-Ichi Tanuma; Tadaharu Kobayashi
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

2.  Ototoxicity after platinum-based chemotherapy in the treatment of melanotic neuroectodermal tumour of infancy.

Authors:  Dorota Hojan-Jezierska; Anna Chomiak; Agata Czopor; Maja Matthews-Kozanecka; Anna Majewska; Marta Urbaniak-Olejnik; Teresa Matthews-Brzozowska
Journal:  Oncol Lett       Date:  2020-03-05       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.